3/26
05:05 pm
abvx
Abivax publishes financial reports with the French and U.S. securities regulatory agencies
Medium
Report
Abivax publishes financial reports with the French and U.S. securities regulatory agencies
3/24
03:30 am
abvx
Abivax Announces Full Year 2024 Financial Results
Low
Report
Abivax Announces Full Year 2024 Financial Results
3/20
08:05 am
abvx
ABIVAX Société Anonyme (NASDAQ: ABVX) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $12.00 price target on the stock.
Medium
Report
ABIVAX Société Anonyme (NASDAQ: ABVX) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $12.00 price target on the stock.
2/21
02:30 am
abvx
Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
Medium
Report
Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
1/28
02:30 am
abvx
Abivax Publishes 2025 Financial Calendar
Medium
Report
Abivax Publishes 2025 Financial Calendar
1/23
04:05 pm
abvx
Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
Low
Report
Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress